Teladoc Health (NYSE:TDOC) Hits New 52-Week Low on Analyst Downgrade

Teladoc Health, Inc. (NYSE:TDOC)’s share price hit a new 52-week low on Monday after Jefferies Financial Group lowered their price target on the stock from $10.00 to $8.00. Jefferies Financial Group currently has a hold rating on the stock. Teladoc Health traded as low as $6.38 and last traded at $6.45, with a volume of 2474952 shares traded. The stock had previously closed at $6.83.

Several other brokerages also recently commented on TDOC. Bank of America reduced their price objective on shares of Teladoc Health from $9.50 to $8.00 and set a “neutral” rating for the company in a research report on Friday, April 11th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. The Goldman Sachs Group dropped their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Monday, March 3rd. Oppenheimer reduced their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Finally, Royal Bank of Canada upped their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $10.82.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 11,011 shares of the company’s stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.95% of the stock is owned by insiders.

Institutional Trading of Teladoc Health

A number of large investors have recently bought and sold shares of the company. Point72 Asset Management L.P. increased its holdings in Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock worth $101,625,000 after acquiring an additional 2,813,568 shares during the last quarter. Maple Rock Capital Partners Inc. increased its stake in shares of Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after purchasing an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP purchased a new position in shares of Teladoc Health in the fourth quarter worth about $18,348,000. Two Sigma Advisers LP raised its position in shares of Teladoc Health by 213.0% in the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock valued at $20,532,000 after purchasing an additional 1,537,094 shares during the period. Finally, Vanguard Group Inc. lifted its stake in shares of Teladoc Health by 5.9% during the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after buying an additional 1,029,829 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Stock Performance

The company has a market capitalization of $1.14 billion, a P/E ratio of -1.13 and a beta of 1.73. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company’s fifty day moving average is $9.05 and its 200 day moving average is $9.62.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. As a group, equities analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.